Pfizer Announcements
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
09 Apr, 2026 | 05:51pm • Source: BSE
Newspaper Advertisement - Special Window for Re - lodgement of transfer and Dematerialization of Physical Securities.
08 Apr, 2026 | 08:00pm • Source: BSE
The trading window for trading in shares of the Company shall remain closed from Tuesday, March 31, 2026 (close of business) till 48 hours after...
28 Mar, 2026 | 03:04pm • Source: BSE
Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve...
30 Jan, 2026 | 04:45pm • Source: BSE
Pfizer Limited has informed the Exchange about change in Management
20 Jan, 2026 | 10:36am • Source: NSE
Intimation regarding change in Senior Management
20 Jan, 2026 | 09:26am • Source: BSE
Pfizer Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
09 Jan, 2026 | 12:20pm • Source:
Please find enclosed herewith the certificate confirming compliance with Regulation 74(5) of the SEBI (DP) Regulations, 2018, for the quarter ended December, 31, 2025.
09 Jan, 2026 | 12:04pm • Source: BSE
This is to inform you that the trading window for trading in shares of the Company shall remain closed from Wednesday, December 31, 2025 (close...
29 Dec, 2025 | 04:05pm • Source: BSE
Intimation pursuant to Regulation 30 of SEBI LODR regarding receipt of an order levying penalty from GST Authorities.
28 Dec, 2025 | 12:37pm • Source: BSE
Intimation pursuant to Regulation 30 of SEBI LODR regarding receipt of an order levying penalty from GST Authorities.
24 Dec, 2025 | 06:25pm • Source: BSE
Intimation regarding change in Senior Management Personnel of the Company - Resignation of Ms. Aditi Mehta - Category Lead, Vaccines.
23 Dec, 2025 | 01:41pm • Source: BSE
Press Release in respect of an exclusive Supply & Marketing Arrangement with Cipla Limited for certain brands.
19 Dec, 2025 | 11:34am • Source: BSE
Exclusive Supply and Marketing Arrangement with Cipla Limited for Pfizer Limited''s Brands Corex Dx, Corex LS, Dolonex and Neksium.
19 Dec, 2025 | 11:31am • Source: BSE
Pursuant to Regulations 30 and 33 of the Listing Regulations, we submit herewith the Unaudited Financial Results of the Company for the quarter and half...
12 Nov, 2025 | 03:37pm • Source: BSE
Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve...
03 Nov, 2025 | 06:02pm • Source: BSE
Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.
08 Oct, 2025 | 05:44pm • Source: BSE
We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company for the quarter and half year...
29 Sep, 2025 | 05:40pm • Source: BSE